Cancer Therapy Decisions: When to Continue, Pause or Stop? CardioOncology Insights | JACC:Asia Pulse

26 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this How-To video as part of the JACC: Asia Pulse Cardio-Oncology Series, Maria Katrina Tan, MD, PCP, PCC, PSE, FICOS, of St. Luke’s Medical Center Global City and Quezon City, Philippines, addresses a critical clinical question: when cancer therapy–related cardiovascular toxicity (CTR-CVT) occurs, how should clinicians decide whether to continue, pause, or stop treatment? Through a practical, case-based framework, she outlines key considerations including cardiovascular risk assessment, severity of toxicity, multidisciplinary coordination, and shared decision-making with patients. This concise, clinically focused discussion provides actionable guidance to help clinicians balance oncologic efficacy with cardiovascular safety in real-world practice.
#jaccasiapulse #cardiooncology #globalcardiology #ctrcvt #cardiotoxicity #cancertherapy #cancertreatmentdecisions #heartfailurerisk #ejectionfraction

Additional information:
https://www.jacc.org/jacc-asia/pulse
https://www.jacc.org/journal/jacc-asia
https://www.jacc.org/
Categoria
Oncology
Commenta per primo questo video.

Prossimo